SCHEMBL9921890

SCHEMBL9921890

c1cc(-c2cccc(-c3cccc(-c4cccc(-n5c6ccccc6c6ncccc65)c4)n3)n2)cc(-n2c3ccccc3c3ncccc32)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.39
HTR7 P34969 1/20 0.39
KDM4E B2RXH2 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
ALPL P05186 1/20 0.37
HSP90AA1 P07900 1/20 0.37
ALPI P09923 1/20 0.37
ALPG P10696 1/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37
CCR1 P32246 1/20 0.37
HTT P42858 1/20 0.37
CCR5 P51681 1/20 0.37
CCR8 P51685 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ATM Q13315 1/20 0.37
ALDH1A1 P00352 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4561486 0.94 HTR1A (0.35) HTR1AHTR7KDM4EL3MBTL1LMNA
SCHEMBL12919193 0.93 TUBB4A (0.37) HTR1AHTR7KDM4ELMNATP53
SCHEMBL9921846 0.91 MAOA (0.36) HTR1AHTR7KDM4EL3MBTL1ATM
SCHEMBL12919283 0.91 GRM5 (0.36) HTR1AHTR7KDM4EL3MBTL1ATM
SCHEMBL12011925 0.89 HTR1A (0.40) HTR1AHTR7KDM4EL3MBTL1LMNA
SCHEMBL9968180 0.89 L3MBTL1 (0.43) HTR1AHTR7KDM4EL3MBTL1HSP90AA1
SCHEMBL15761442 0.89 MAPT (0.36) HTR1AHTR7KDM4EL3MBTL1ATM
SCHEMBL19271536 0.88 KMT2A (0.41) KDM4EL3MBTL1MAPK1CCR1CCR8
SCHEMBL12011908 0.88 HTR1A (0.39) HTR1AHTR7KDM4EL3MBTL1LMNA
SCHEMBL15855405 0.88 KDM4E (0.42) HTR1AHTR7KDM4EL3MBTL1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2241568-B1 COMPOUND HAVING SUBSTITUTED PYRIDYL GROUP AND PYRIDOINDOLE RING STRUCTURE LINKED THROUGH PHENYLENE GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO LTD (JP) 2014-09-10 EP disclosed
US-8377573-B2 Compound having substituted pyridyl group and pyridoindole ring structure linked through phenylene group, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2013-02-19 US disclosed
US-8377573-B2 Compound having substituted pyridyl group and pyridoindole ring structure linked through phenylene group, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2013-02-19 US disclosed
EP-2463288-A1 Compound having substituted pyridyl group and pyridoindole ring structure linked through phenylene group, and organic electroluminescent device Hodogaya Chemical Co., Ltd. (JP) 2012-06-13 EP disclosed
US-20110006291-A1 COMPOUND HAVING SUBSTITUTED PYRIDYL GROUP AND PYRIDOINDOLE RING STRUCTURE LINKED THROUGH PHENYLENE GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO. LTD. (JP) 2011-01-13 US disclosed
US-20110006291-A1 COMPOUND HAVING SUBSTITUTED PYRIDYL GROUP AND PYRIDOINDOLE RING STRUCTURE LINKED THROUGH PHENYLENE GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO. LTD. (JP) 2011-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110006291-A1 COMPOUND HAVING SUBSTITUTED PYRIDYL GROUP AND PYRIDOINDOLE RING STRUCTURE LINKED THROUGH PHENYLENE GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE KCNH3, KCNH2, CHRNA9 HTR1A 722/4885HTR7 984/4885KDM4E 572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.